Content |
Biography
2021: Appointment as CEO of Fujifilm Holdings
On March 31, 2021, Fujifilm Holdings announced the appointment of Teiichi Goto as the new CEO instead of Shigetaka Komori, who has led the Japanese company since 2003.
81-year-old Komori also resigns as chairman of the board of directors of Fujifilm. It will be occupied by the president and executive director of the holding Kenji Sukeno. The appointments will take effect in June 2021 after they are formally approved by shareholders at the meeting.
Shigetaki Komori led Fujifilm at a time when the development of digital technologies led to a rapid decrease in demand for film and traditional cameras, the production of which was specialized in the Japanese company. Under the leadership of Komori, the manufacturer carried out a large-scale reform, changing its focus to the production of medical equipment and drugs, as well as the development of biotechnology.
According to Reuters, Fujifilm's desire for healthcare has become even more evident in the pandemic, as its antiviral drug Avigan has become used as a treatment for COVID-19. By 2021, the medical sector accounts for 20% of Fujifilm's annual turnover. The company aims to double the revenue of the division in the next five years and make it the second pillar of its business, along with the production of office equipment. Market experts believe Fujifilm has chosen the right path.
Growth in Fujifilm will depend on medical equipment and biopharmaceutical direction, "wrote Tomoki Komiya, an analyst at Mitsubishi UFJ Morgan Stanley Securities, in a recent note to investors. |
Shigetaki Komori, who has worked at Fujifilm since 1963, will remain with the company after leaving the position of CEO and chairman of the board of directors. He will work as a chief adviser. His duties in this position are not reported by the end of March 2021.[1]